Advisor Net Financial, Inc Regeneron Pharmaceuticals, Inc. Transaction History

Advisor Net Financial, Inc

$1.46 Billion
Q2 2025

A detailed history of Advisor Net Financial, Inc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Advisor Net Financial, Inc holds 61 shares of REGN stock, worth $36,600. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 75 18.67%

Holding current value

$36,600

Previous $47,000 31.91%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 14, 2025	SELL	$483.07 - $625.6 $6,762 - $8,758	-14 Reduced 18.67%	61 $32,000
Q1 2025 Apr 07, 2025	SELL	$634.14 - $744.83 $1,902 - $2,234	-3 Reduced 3.85%	75 $47,000
Q4 2024 Jan 13, 2025	SELL	$701.85 - $1046.91 $15,440 - $23,032	-22 Reduced 22.0%	78 $55,000
Q3 2024 Oct 15, 2024	BUY	$1024.09 - $1201.76 $31,746 - $37,254	31 Added 44.93%	100 $105,000
Q1 2024 Apr 12, 2024	SELL	$902.69 - $993.35 $30,691 - $33,773	-34 Reduced 33.01%	69 $66,000
Q4 2023 Jan 19, 2024	SELL	$775.18 - $881.7 $15,503 - $17,634	-20 Reduced 16.26%	103 $90,000
Q3 2023 Oct 12, 2023	SELL	$692.45 - $844.37 $83,786 - $102,168	-121 Reduced 49.59%	123 $101,000
Q2 2023 Jul 14, 2023	SELL	$700.03 - $830.35 $8,400 - $9,964	-12 Reduced 4.69%	244 $175,000
Q1 2023 Apr 28, 2023	BUY	$680.49 - $826.97 $680 - $826	1 Added 0.39%	256 $210,000
Q4 2022 Jan 13, 2023	BUY	$705.89 - $766.39 $14,823 - $16,094	21 Added 8.97%	255 $0
Q3 2022 Oct 04, 2022	SELL	$573.97 - $724.32 $2,869 - $3,621	-5 Reduced 2.09%	234 $161,000
Q2 2022 Jul 07, 2022	BUY	$548.35 - $738.84 $66,898 - $90,138	122 Added 104.27%	239 $141,000
Q1 2022 Apr 14, 2022	SELL	$595.12 - $698.43 $7,736 - $9,079	-13 Reduced 10.0%	117 $82,000
Q4 2021 Jan 19, 2022	BUY	$543.48 - $670.97 $1,086 - $1,341	2 Added 1.56%	130 $82,000
Q3 2021 Oct 15, 2021	BUY	$574.03 - $680.96 $574 - $680	1 Added 0.79%	128 $77,000
Q2 2021 Jul 06, 2021	SELL	$472.8 - $558.54 $8,037 - $9,495	-17 Reduced 11.81%	127 $71,000
Q1 2021 Apr 14, 2021	SELL	$446.73 - $548.2 $7,147 - $8,771	-16 Reduced 10.0%	144 $68,000
Q4 2020 Feb 04, 2021	SELL	$478.3 - $607.98 $19,610 - $24,927	-41 Reduced 20.4%	160 $77,000
Q3 2020 Nov 06, 2020	BUY	$544.75 - $658.21 $13,618 - $16,455	25 Added 14.2%	201 $113,000
Q2 2020 Aug 26, 2020	BUY	$493.32 - $643.92 $36,999 - $48,294	75 Added 74.26%	176 $110,000
Q1 2020 May 14, 2020	BUY	$336.18 - $494.43 $7,059 - $10,383	21 Added 26.25%	101 $49,000
Q3 2019 Oct 23, 2019	SELL	$273.46 - $318.39 $273 - $318	-1 Reduced 1.23%	80 $22,000
Q2 2019 Jul 15, 2019	BUY	$299.6 - $414.82 $1,198 - $1,659	4 Added 5.19%	81 $25,000
Q4 2018 Feb 08, 2019	BUY	$335.82 - $403.04 $17,462 - $20,958	52 Added 208.0%	77 $29,000
Q4 2017 Feb 27, 2018	BUY	$358.63 - $469.95 $8,965 - $11,748	25	25 $9,000

Others Institutions Holding REGN

# of Institutions

1,418

Shares Held

88.7M

Call Options Held

1.98M

Put Options Held

1.75M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $64.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Net Financial, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Advisor Net Financial, Inc with notifications on news.

Account

Advisor Net Financial, Inc Regeneron Pharmaceuticals, Inc. Transaction History